Global Cartilage Degeneration Therapy Industry
Global Cartilage Degeneration Therapy Market to Reach $15.7 Billion by 2027
NEW YORK, Dec. 1, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for Cartilage Degeneration Therapy estimated at US$10.9 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Joint Replacements, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$5.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chondroplasty segment is readjusted to a revised 5.6% CAGR for the next 7-year period.
Read the full report: https://www.reportlinker.com/p05960838/?utm_source=PRN
The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 5.1% CAGR
The Cartilage Degeneration Therapy market in the U.S. is estimated at US$3.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
Osteochondral Transplants Segment to Record 5.1% CAGR
In the global Osteochondral Transplants segment, USA, Canada, Japan, China and Europe will drive the 5.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.7 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 192-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- B. Braun Melsungen AG
- DePuy Synthes
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
Read the full report: https://www.reportlinker.com/p05960838/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Cartilage Degeneration Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Cartilage
Degeneration Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027
Table 2: World Historic Review for Cartilage Degeneration
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019
Table 3: World 15-Year Perspective for Cartilage Degeneration
Therapy by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Joint Replacements
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 5: World Historic Review for Joint Replacements by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019
Table 6: World 15-Year Perspective for Joint Replacements by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Chondroplasty by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 8: World Historic Review for Chondroplasty by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 9: World 15-Year Perspective for Chondroplasty by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Osteochondral
Transplants by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027
Table 11: World Historic Review for Osteochondral Transplants
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019
Table 12: World 15-Year Perspective for Osteochondral
Transplants by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Microfracture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 14: World Historic Review for Microfracture by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 15: World 15-Year Perspective for Microfracture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Meniscus
Transplants by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027
Table 17: World Historic Review for Meniscus Transplants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019
Table 18: World 15-Year Perspective for Meniscus Transplants by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Cell based
Cartilage Resurfacing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027
Table 20: World Historic Review for Cell based Cartilage
Resurfacing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019
Table 21: World 15-Year Perspective for Cell based Cartilage
Resurfacing by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Autologus
Chondrocyte Implantation by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027
Table 23: World Historic Review for Autologus Chondrocyte
Implantation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019
Table 24: World 15-Year Perspective for Autologus Chondrocyte
Implantation by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Other Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 26: World Historic Review for Other Types by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 27: World 15-Year Perspective for Other Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Knee by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 29: World Historic Review for Knee by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019
Table 30: World 15-Year Perspective for Knee by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 31: World Current & Future Analysis for Hip by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027
Table 32: World Historic Review for Hip by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019
Table 33: World 15-Year Perspective for Hip by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 34: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027
Table 35: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019
Table 36: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Cartilage Degeneration Market Share (in %) by Company: 2019 &
2025
Market Analytics
Table 37: USA Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 38: USA Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 39: USA 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 40: USA Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 41: USA Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 42: USA 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
CANADA
Table 43: Canada Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 44: Canada Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 45: Canada 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 46: Canada Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 47: Canada Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 48: Canada 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
JAPAN
Table 49: Japan Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 50: Japan Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 51: Japan 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 52: Japan Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 53: Japan Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 54: Japan 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
CHINA
Table 55: China Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 56: China Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 57: China 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 58: China Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 59: China Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 60: China 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
EUROPE
Market Facts & Figures
European Cartilage Degeneration Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 61: Europe Current & Future Analysis for Cartilage
Degeneration Therapy by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027
Table 62: Europe Historic Review for Cartilage Degeneration
Therapy by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019
Table 63: Europe 15-Year Perspective for Cartilage Degeneration
Therapy by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027
Table 64: Europe Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 65: Europe Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 66: Europe 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 67: Europe Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 68: Europe Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 69: Europe 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
FRANCE
Table 70: France Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 71: France Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 72: France 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 73: France Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 74: France Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 75: France 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
GERMANY
Table 76: Germany Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 77: Germany Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 78: Germany 15-Year Perspective for Cartilage
Degeneration Therapy by Type - Percentage Breakdown of Value
Sales for Joint Replacements, Chondroplasty, Osteochondral
Transplants, Microfracture, Meniscus Transplants, Cell based
Cartilage Resurfacing, Autologus Chondrocyte Implantation and
Other Types for the Years 2012, 2020 & 2027
Table 79: Germany Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 80: Germany Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 81: Germany 15-Year Perspective for Cartilage
Degeneration Therapy by Application - Percentage Breakdown of
Value Sales for Knee, Hip and Other Applications for the Years
2012, 2020 & 2027
ITALY
Table 82: Italy Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 83: Italy Historic Review for Cartilage Degeneration
Therapy by Type - Joint Replacements, Chondroplasty,
Osteochondral Transplants, Microfracture, Meniscus Transplants,
Cell based Cartilage Resurfacing, Autologus Chondrocyte
Implantation and Other Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 84: Italy 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 85: Italy Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 86: Italy Historic Review for Cartilage Degeneration
Therapy by Application - Knee, Hip and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 87: Italy 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
UNITED KINGDOM
Table 88: UK Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 89: UK Historic Review for Cartilage Degeneration Therapy
by Type - Joint Replacements, Chondroplasty, Osteochondral
Transplants, Microfracture, Meniscus Transplants, Cell based
Cartilage Resurfacing, Autologus Chondrocyte Implantation and
Other Types Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 90: UK 15-Year Perspective for Cartilage Degeneration
Therapy by Type - Percentage Breakdown of Value Sales for Joint
Replacements, Chondroplasty, Osteochondral Transplants,
Microfracture, Meniscus Transplants, Cell based Cartilage
Resurfacing, Autologus Chondrocyte Implantation and Other Types
for the Years 2012, 2020 & 2027
Table 91: UK Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 92: UK Historic Review for Cartilage Degeneration Therapy
by Application - Knee, Hip and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 93: UK 15-Year Perspective for Cartilage Degeneration
Therapy by Application - Percentage Breakdown of Value Sales
for Knee, Hip and Other Applications for the Years 2012, 2020 &
2027
REST OF EUROPE
Table 94: Rest of Europe Current & Future Analysis for
Cartilage Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 95: Rest of Europe Historic Review for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 96: Rest of Europe 15-Year Perspective for Cartilage
Degeneration Therapy by Type - Percentage Breakdown of Value
Sales for Joint Replacements, Chondroplasty, Osteochondral
Transplants, Microfracture, Meniscus Transplants, Cell based
Cartilage Resurfacing, Autologus Chondrocyte Implantation and
Other Types for the Years 2012, 2020 & 2027
Table 97: Rest of Europe Current & Future Analysis for
Cartilage Degeneration Therapy by Application - Knee, Hip and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027
Table 98: Rest of Europe Historic Review for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 99: Rest of Europe 15-Year Perspective for Cartilage
Degeneration Therapy by Application - Percentage Breakdown of
Value Sales for Knee, Hip and Other Applications for the Years
2012, 2020 & 2027
ASIA-PACIFIC
Table 100: Asia-Pacific Current & Future Analysis for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 101: Asia-Pacific Historic Review for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 102: Asia-Pacific 15-Year Perspective for Cartilage
Degeneration Therapy by Type - Percentage Breakdown of Value
Sales for Joint Replacements, Chondroplasty, Osteochondral
Transplants, Microfracture, Meniscus Transplants, Cell based
Cartilage Resurfacing, Autologus Chondrocyte Implantation and
Other Types for the Years 2012, 2020 & 2027
Table 103: Asia-Pacific Current & Future Analysis for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 104: Asia-Pacific Historic Review for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 105: Asia-Pacific 15-Year Perspective for Cartilage
Degeneration Therapy by Application - Percentage Breakdown of
Value Sales for Knee, Hip and Other Applications for the Years
2012, 2020 & 2027
REST OF WORLD
Table 106: Rest of World Current & Future Analysis for
Cartilage Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 107: Rest of World Historic Review for Cartilage
Degeneration Therapy by Type - Joint Replacements,
Chondroplasty, Osteochondral Transplants, Microfracture,
Meniscus Transplants, Cell based Cartilage Resurfacing,
Autologus Chondrocyte Implantation and Other Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 108: Rest of World 15-Year Perspective for Cartilage
Degeneration Therapy by Type - Percentage Breakdown of Value
Sales for Joint Replacements, Chondroplasty, Osteochondral
Transplants, Microfracture, Meniscus Transplants, Cell based
Cartilage Resurfacing, Autologus Chondrocyte Implantation and
Other Types for the Years 2012, 2020 & 2027
Table 109: Rest of World Current & Future Analysis for
Cartilage Degeneration Therapy by Application - Knee, Hip and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027
Table 110: Rest of World Historic Review for Cartilage
Degeneration Therapy by Application - Knee, Hip and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019
Table 111: Rest of World 15-Year Perspective for Cartilage
Degeneration Therapy by Application - Percentage Breakdown of
Value Sales for Knee, Hip and Other Applications for the Years
2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 42
Read the full report: https://www.reportlinker.com/p05960838/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article